Table 1—

Clinical characteristics at baseline in the two treatment groups

GlibenclamideInsulin
n2118
Age (years)55.6 ± 1.651.1 ± 1.7
Sex (M/F)15/611/7
BMI (kg/m2)27.8 ± 0.827.3 ± 0.7
HbA1c (%)6.9 ± 0.27.3 ± 0.4
AER (mg/l)9.7 ± 3.58.8 ± 2.1
Systolic blood pressure (mmHg)139 ± 3 (18)144 ± 7 (16)
Diastolic blood pressure (mmHg)85 ± 283 ± 2
Retinopathy3/193/16
Total cholesterol (mmol/l)5.39 ± 0.165.47 ± 0.24
LDL cholesterol (mmol/l)3.39 ± 0.133.40 ± 0.20
HDL cholesterol (mmol/l)1.06 ± 0.061.09 ± 0.04
Triglycerides (mmol/l)2.25 ± 0.262.06 ± 0.16
  • Data are mean ± SEM or mean ± SEM (n).